13th Annual Fall Midwest Thoracic and GI Oncology Conference
Playback speed
10 seconds
Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront and Combination of EGFR +IO
554 views
December 19, 2018
Comments 0
Login to view comments.
Click here to Login
Lung